GATA2 and myelodysplastic syndrome: Aim: The aim of the study was to characterize the HSCT outcome of pediatric patients with MDS and GATA2 germline mutations (GATA2mut) and compare it to MDS without GATA2 deficiency or any other known underlying predisposition (GATA2wt).